ARCHIVES

Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described

This article is from The Cancer Letter archive.

Vol. 01 No. 30 | July 25, 1975

Download PDF Visit The Full Archive

Related Articles

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012

Particle Therapy Program Would cost $600 million Over 10 Years for 16 Facilities, Clinical Trials

December 2, 1977

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

DCPC Faces Huge Out Year Costs Of Four Trials

February 15, 1991